Amdocs (DOX) Stock Forecast, Price & News

4 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Amdocs in the last twelve months. There are currently 1 hold rating and 3 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" DOX shares.
View DOX analyst ratings or view top-rated stocks.

4 Wall Street research analysts have issued 12-month target prices for Amdocs' shares. Their DOX share price forecasts range from $96.00 to $115.00. On average, they anticipate the company's stock price to reach $102.50 in the next year. This suggests a possible upside of 9.8% from the stock's current price.
View analysts price targets for DOX or view top-rated stocks among Wall Street analysts.

Amdocs' stock was trading at $90.90 at the start of the year. Since then, DOX stock has increased by 2.7% and is now trading at $93.39.
View the best growth stocks for 2023 here.

Amdocs saw a increase in short interest in the month of May. As of May 15th, there was short interest totaling 1,440,000 shares, an increase of 5.9% from the April 30th total of 1,360,000 shares. Based on an average daily trading volume, of 643,500 shares, the days-to-cover ratio is currently 2.2 days. Currently, 1.2% of the company's shares are short sold.
View Amdocs' Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Wednesday, August 2nd 2023.
View our DOX earnings forecast.

Amdocs Limited (NASDAQ:DOX) posted its quarterly earnings data on Tuesday, November, 2nd. The technology company reported $1.16 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $1.18 by $0.02. The technology company had revenue of $1.09 billion for the quarter, compared to the consensus estimate of $1.11 billion. Amdocs had a net margin of 11.33% and a trailing twelve-month return on equity of 16.92%. During the same quarter in the prior year, the company posted $1.17 EPS.

Amdocs announced a quarterly dividend on Wednesday, May 10th. Shareholders of record on Friday, June 30th will be paid a dividend of $0.435 per share on Friday, July 28th. This represents a $1.74 annualized dividend and a yield of 1.86%. The ex-dividend date is Thursday, June 29th.
Read our dividend analysis for DOX.

ETFs with the largest weight of Amdocs (NASDAQ:DOX) stock in their portfolio include BlueStar Israel Technology ETF (ITEQ), VanEck Israel ETF (ISRA), AAM Bahl & Gaynor Small/Mid Cap Income Growth ETF (SMIG), Formidable Fortress ETF (KONG), American Century Low Volatility ETF (LVOL), Ballast Small/Mid Cap ETF (MGMT), ALPS O'Shares U.S. Small-Cap Quality Dividend ETF (OUSM) and Defiance Next Gen Connectivity ETF (FIVG).

Amdocs (NASDAQ:DOX) pays an annual dividend of $1.74 per share and currently has a dividend yield of 1.85%. The company has been increasing its dividend for 10 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio is 39.64%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, DOX will have a dividend payout ratio of 29.00% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for DOX.

Amdocs issued an update on its third quarter 2023 earnings guidance on Friday, May, 12th. The company provided EPS guidance of $1.45-$1.51 for the period, compared to the consensus EPS estimate of $1.48. The company issued revenue guidance of $1.22 billion-$1.25 billion, compared to the consensus revenue estimate of $1.23 billion.

2,315 employees have rated Amdocs Chief Executive Officer Shuky Sheffer on Glassdoor.com. Shuky Sheffer has an approval rating of 90% among the company's employees. 83.0% of employees surveyed would recommend working at Amdocs to a friend.

Based on aggregate information from My MarketBeat watchlists, some companies that other Amdocs investors own include Home Depot (HD), Pfizer (PFE), AT&T (T), NVIDIA (NVDA), Exxon Mobil (XOM), AbbVie (ABBV), International Business Machines (IBM), Johnson & Johnson (JNJ), Advanced Micro Devices (AMD) and Comcast (CMCSA).

Amdocs trades on the NASDAQ under the ticker symbol "DOX."

Amdocs' stock is owned by many different retail and institutional investors. Top institutional investors include FMR LLC (12.26%), Allspring Global Investments Holdings LLC (4.01%), Pzena Investment Management LLC (3.95%), BlackRock Inc. (3.21%), LSV Asset Management (2.70%) and Clal Insurance Enterprises Holdings Ltd (1.97%).

Shares of DOX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of DOX stock can currently be purchased for approximately $93.39.

Amdocs (NASDAQ:DOX) has a market capitalization of $11.28 billion and generates $4.58 billion in revenue each year. The technology company earns $549.50 million in net income (profit) each year or $4.39 on an earnings per share basis.

The company employs 30,288 workers across the globe.

Amdocs' mailing address is 1390 Timberlake Manor Parkway, Chesterfield MO, 63017. The official website for the company is www.amdocs.com. The technology company can be reached via phone at (314) 212-7000, via email at dox_info@amdocs.com, or via fax at 1 314 212 7500.